10.5 C
New York
Sunday, April 2, 2023

Are Things Looking Up For Inovio Pharmaceuticals Inc. (NASDAQ: INO)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Inovio Pharmaceuticals Inc. (INO) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $1.32. The Inovio Pharmaceuticals Inc. has recorded 151,627 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.32 and fluctuated between $1.3500 as its day high and $1.2700 as its day low. The current market capitalization of Inovio Pharmaceuticals Inc. is $324.30M. A total of 3.39 million shares were traded on the day, compared to an average of 4.75M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, INO has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 4,273 and the disposition of 0 shares. Over the last 12 months, there were 23 BUYs and 16 SELLs from insiders. Insiders purchased 667,821 shares during that period but sold 218,597.

In the most recent transaction, Weiner David B. sold 11,668 shares of INO for 1.28 per share on Feb 27. After the transaction, the Director now owns 904,291 company shares. In a previous transaction on Aug 11, Weiner David B. sold 11,875 shares at 2.66 per share. INO shares that Director owns now total 892,625.

Among the insiders who sold shares, BENITO SIMON X disposed of 2,000 shares on Jul 20 at a per-share price of $2.25. This resulted in the Director holding 75,305 shares of INO after the transaction. In another insider transaction, Weiner David B. sold 9,000 shares at $1.95 per share on May 16. Company shares held by the Director now total 892,625.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. INO’s most recent ex-dividend date was 9/28/2017 when it declared a $0.0690 quarterly dividend that was paid in cash on 10/16/2017. Previously, the company paid the dividend on 9/15/2017 with an ex-dividend date of 8/29/2017. The INO stock dividend was $0.0690 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for INO in the last 3 months, the mean price target is $1.40 with high estimates of $2.00 and low estimates of $1.00. In terms of 52-week highs and lows, INO has a high of $4.00 and a low of $1.19.

As of this writing, INO has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.19. The company reported an EPS of -$0.46 in the last quarter, which was -48.40% lower than expectations of -$0.31.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INO is Overweight with a score of 2.83. A total of 0 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles